Your Money with Michelle Martin
About
Your Money With Michelle Martin (9am - 12pm) It’s all about Your Money with Michelle Martin from 9am to 12pm. How to save, invest and make the best financial decisions for yourself. Listen to inspiring thinkers with “Influence” and hear from great authors in “Read”.
OCT 28, 2020
28/10/20 - HSBC's earnings and potential new business model, Microsoft, Pfizer, Merck and MTI earnings, Las Vegas Sands exploring sale of Vegas properties and a plot on Oxley Rise on saleMichelle Martin speaks to Ryan Huang to discuss HSBC's better than expected earnings and the banks' consideration that it will restart paying dividends, HSBC's plans to flip its main source of income from interest rates to fees, Microsoft, Pfizer, Merck and Mapletree Industrial Trust's earnings, Las Vegas Sands exploring sale of Vegas properties for 8.2 billion USD and a site in District 9 in Singapore up for sale.
|
|
|
|
11:42
|
OCT 27, 2020
27/10/20 - Why No Rules, Rules at NetflixMichelle Martin speaks with co-author of the book No Rules Rules, Erin Meyer to understand how the lack of rules at Netflix enables a corporate culture where creativity and high-performance can thrive.
Guest: Erin Meyer, author and INSEAD Business School Professor.
|
|
|
|
|
20:12
|
OCT 27, 2020
27/10/20 - Company in the Spotlight - TwilioTwilio's revenue vaulted 52% to $447.9 million from $295.1 million a year ago and its fiscal 3rd quarter revenue outdid estimates.
Michelle Martin speaks with Glenn Weinstein, Chief Customer Officer at Twilio to learn how in an economy roiled by a pandemic, the cloud communications company is benefitting and how it is helping businesses make crucial digital pivots.
|
|
|
|
|
12:28
|
OCT 27, 2020
27/10/20 - Sell off in US stocks, China to sanction Boeing over US arms sale to Taiwan, AstraZeneca breakthrough, Ant Group to list and Dunkin Donuts looking to go privateOn Market View, Michelle Martin and Ryan Huang discuss the top few reasons for the sell-off in US stocks - COVID-19 cases on the rise and ongoing stimulus negotiations, China to sanction Boeing and other US firms over arms sale to Taiwan, AstraZeneca's promotes an immune response among adults, Ant Group's listing next week, Dunkin' Donuts looking to go private and a couple in New York accidentally served the wrong bottle of wine.
|
|
|
|
|
09:16
|
OCT 26, 2020
26/10/20 - The Tech Divide - How will Digitalization, Digital Currencies, Payment Systems set a new business order?Michelle Martin speaks to Krishna Ramachandra, Managing Director, Duane Morris and Selvam LLC and Senior Advisor to the Global Blockchain Foundation and Chairman of the Helix Initiative to discuss the future of global finance and the evolving business order.
|
|
|
|
|
24:22
|
OCT 26, 2020
26/10/20 - Upcoming FAANG earning expectations, Google, Facebook and Twitter to testify in Congress, Mr DIY's IPOMichelle Martin speaks to Ryan Huang to discuss expectations for the upcoming FAANG earnings, the chiefs of Google, Facebook and Twitter to appear before the US Congress to discuss the rules that govern the companies content policies, a record number of COVID-19 cases in the US and Mike Pence's chief of staff testing positive for the infection and Malaysian home improvement retailer, Mr DIY's IPO.
|
|
|
|
|
12:09
|
OCT 23, 2020
23/10/20 - Tracking the final US Presidential Debate liveMichelle Martin speaks to Jeffrey Halley, Senior Market Analyst at OANDA to break down possible investor reaction to the debate and key topics from COVID-19 to foreign policy to impact on America's economy.
|
|
|
|
|
19:01
|
OCT 23, 2020
23/10/20 - Pushing the boundaries for organic foodMichelle Martin speaks to Seng Yee Tai, Executive Director of Zenxin Organic Food to discuss organic foods, maintaining the price point to make organic food accessible and bringing the business into the future.
|
|
|
|
|
15:05
|
OCT 23, 2020
23/10/20 - US FDA approves remdesivir for hospitalised COVID-19 patients, Goldman's fine over 1MDB largest ever in a corruption case, China's feeder ETFsMichelle Martin and Ryan Huang discuss Gilead's remdesivir's approval by the US FDA for hospitalised COVID-19 patients, the US economy and COVID-19 in early minutes of the final presidential debate, Goldman facing the largest ever fine in a corruption case in the US and Singapore's fine of 165 million Singapore dollars over 1MDB, China's feeder ETFs available to overseas investors and early trading for the STI.
|
|
|
|
|
11:00
|
OCT 22, 2020
22/10/20 - Tesla earnings, Morgan Stanley's outlook on a blue wave bringing out FED rate hikes, Netflix's earnings, Brazil potentially blocking Huawei and SEC Chair's advise to investorsMichelle Martin speaks to Arun Pai, Chief Strategy Officer at Flow to break down Tesla's, earnings report, Morgan Stanley's thesis about a blue wave bringing out FED rate hikes, Netflix's earnings and prospects, the implications of a stimulus deal in the US for markets, the US looking to Brazil to block Huawei from next generation 5G networks and his take on SEC Chair Jay Clayton's statement that regular investors should stay away from high leverage and embedded option contracts.
|
|
|
|
|
26:12
|
